| [1] |
CHEN W, ZHENG R, BAADE P D, et al.Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| [2] |
AMITAY E L, WERNER S, VITAL M, et al.Fusobacterium and colorectal cancer: Causal factor or passenger? Results from a large colorectal cancer screening study[J]. Carcinogenesis, 2017, 38(8):781-788.
|
| [3] |
ALLALI I, BOUKHATEM N, BOUGUENOUCH L, et al.Gut microbiome of Moroccan colorectal cancer patients[J]. Med Microbiol Immunol, 2018, 207(3-4):211-225.
|
| [4] |
HAN Y W.Commentary: Oral bacteria as drivers for colorectal cancer[J]. J Periodontol, 2014, 85(9):1155-1157.
|
| [5] |
GHOLIZADEH P, ESLAMI H, KAFIL H S.Carcinogenesis mechanisms of Fusobacterium nucleatum[J]. Biomed Pharmacother, 2017, 89:918-925.
|
| [6] |
MIMA K, SUKAWA Y, NISHIHARA R, et al.Fusobacterium nucleatum and T Cells in colorectal carcinoma[J]. JAMA Oncol, 2015, 1(5):653-661.
|
| [7] |
LI Z, ZHANG L J, ZHANG H R, et al.Tumor-derived transforming growth factor-beta is critical for tumor progression and evasion from immune surveillance[J]. Asian Pac J Cancer Prev, 2014, 15(13):5181-5186.
|
| [8] |
LI N, XIE C, LU N H.Transforming growth factor-beta: An important mediator in Helicobacter pylori-associated pathogenesis[J]. Front Cell Infect Microbiol, 2015,5:77.
|
| [9] |
GIL J H, SEO J W, CHO M S, et al.Role of Treg and TH17 cells of the gastric mucosa in children with Helicobacter pylori gastritis[J]. J Pediatr Gastroenterol Nutr, 2014, 58(2):245-251.
|
| [10] |
HAMADA T, ZHANG X, MIMA K, et al.Fusobacterium nucleatum in colorectal cancer relates to immune response differentially by tumor microsatellite instability status[J]. Cancer Immunol Res, 2018, 6(11):1327-1336.
|
| [11] |
BAGHERI N, AZADEGAN-DEHKORDI F, RAHIMIAN G, et al.Role of regulatory t-cells in different clinical expressions of Helicobacter pylori infection[J]. Arch Med Res, 2016, 47(4):245-254.
|
| [12] |
尹丹, 曹颖, 王礼鑫, 等. 肠型胃癌细胞中酪蛋白激酶2相互作用蛋白1与转化生长因子β1表达的相关性[J]. 实用医学杂志, 2019,35(2):276-280.
|
| [13] |
CHEN T, LI Q, ZHANG X, et al.TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection[J]. Hum Pathol, 2018, 79:93-101.
|
| [14] |
贾一琼, 朱光发. 调节性B细胞与自身免疫性疾病关系的研究进展[J]. 实用医学杂志, 2018, 34(15):2478-2480.
|
| [15] |
METELLI A, SALEM M, WALLACE C H, et al.Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer[J]. J Hematol Oncol, 2018, 11(1):24.
|
| [16] |
MIYAZONO K, KATSUNO Y, KOINUMA D, et al.Intracellular and extracellular TGF-β signaling in cancer: Some recent topics[J]. Front Med, 2018, 12(4):387-411.
|
| [17] |
AHN S H, CHUN S, PARK C, et al.Transcriptome profiling analysis of senescent gingival fibroblasts in response to Fusobacterium nucleatum infection[J]. PLoS One, 2017, 12(11):e0188755.
|
| [18] |
LI N, XIE C, LU N H.Transforming growth factor-β: An important mediator in Helicobacter pylori-associated pathogenesis[J]. Front Cell Infect Microbiol, 2015, 4(5):77.
|
| [19] |
LEE D W, HAN S W, KANG J K, et al.Association between fusobacterium nucleatum, pathway mutation, and patient prognosis in colorectal cancer[J]. Ann Surg Oncol, 2018, 25(11):3389-3395.
|
| [20] |
SAITO T, NISHIKAWA H, WADA H, et al.Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers[J]. Nat Med, 2016, 22(6):679-684.
|